Article
Bacterial extracellular vesicles as a tunable platform for vaginal drug delivery
2025-06-09
Abstract excerpt
There is a critical gap in the development of new therapeutic platforms designed to treat gynecologic and obstetric diseases. Compared to systemic drug delivery, vaginal drug administration of nanoparticle formulations limits off-target side effects while increasing therapeutic concentration in target tissues, showing promise for clinical translation. However, these formulations suffer from limited scalability, hi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6290f283-bc03-57a1-bcb7-01a4e161eaed
- DOI
- 10.1101/2025.06.09.658669
